Nexalin Technology (NXL) Change in Account Payables (2021 - 2026)
Nexalin Technology's quarterly Change in Account Payables came in at -$76480.0 in Q1 2026, down 400.57% year-on-year from $25445.0 in Q1 2025, and down 142.49% quarter-over-quarter from $179996.0 in Q4 2025.
Nexalin Technology has reported Change in Account Payables for 6 years, with the latest figure at -$76480.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables fell 400.57% year-over-year to -$76480.0; the trailing twelve-month figure through Mar 2026 stood at -$13296.0 (down 144.49% YoY), and the FY2025 full-year result was $88629.0, up 2572.22% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$76480.0, down from $179996.0 in the prior quarter.
- The five-year high for Change in Account Payables was $179996.0 in Q4 2025, with the low at -$353609.0 in Q1 2023.
- Average Change in Account Payables over 5 years is -$16257.4, with a median of $3743.0 recorded in 2023.
- Year-over-year, Change in Account Payables plunged 1819.8% in 2024 and jumped 1799.2% in 2025.
- Tracing NXL's Change in Account Payables over 5 years: stood at -$139926.0 in 2022, then soared by 162.17% to $86985.0 in 2023, then sank by 112.18% to -$10593.0 in 2024, then jumped by 1799.2% to $179996.0 in 2025, then tumbled by 142.49% to -$76480.0 in 2026.
- The last three Change in Account Payables figures came in at -$76480.0 (Q1 2026), $179996.0 (Q4 2025), and -$168228.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Nexalin Technology | 11.19 Mn | 8.48 Mn | 13,133.00 | -76,480.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76,480.00 |
| Mar 31, 2026 | -76,480.00 |
| Dec 31, 2025 | 179,996.00 |
| Dec 31, 2025 | 179,996.00 |
| Sep 30, 2025 | -168,228.00 |
| Sep 30, 2025 | -168,228.00 |
| Jun 30, 2025 | 51,416.00 |
| Jun 30, 2025 | 51,416.00 |
| Mar 31, 2025 | 25,445.00 |
| Mar 31, 2025 | 25,445.00 |
| Dec 31, 2024 | -10,593.00 |
| Dec 31, 2024 | -10,593.00 |
| Sep 30, 2024 | 79,404.00 |
| Sep 30, 2024 | 79,404.00 |
| Jun 30, 2024 | -64,372.00 |
| Jun 30, 2024 | -64,372.00 |
| Mar 31, 2024 | -8,024.00 |
| Mar 31, 2024 | -8,024.00 |
| Dec 31, 2023 | 86,985.00 |
| Dec 31, 2023 | 86,985.00 |
| Sep 30, 2023 | 24,048.00 |
| Sep 30, 2023 | 24,048.00 |
| Jun 30, 2023 | 3,743.00 |
| Jun 30, 2023 | 3,743.00 |
| Mar 31, 2023 | -353,609.00 |
| Mar 31, 2023 | -353,609.00 |
| Dec 31, 2022 | -139,926.00 |
| Dec 31, 2022 | -139,926.00 |
| Sep 30, 2022 | -135,242.00 |
| Sep 30, 2022 | -135,242.00 |
| Jun 30, 2022 | 49,675.00 |
| Jun 30, 2022 | 49,675.00 |
| Mar 31, 2022 | 179,386.00 |
| Mar 31, 2022 | 179,386.00 |
| Dec 31, 2021 | 137,085.00 |
| Dec 31, 2021 | 137,085.00 |